Review Article
You have free access to this content
Chronic myelogenous leukemia: Laboratory diagnosis and monitoring
Article first published online: 25 JUL 2001
DOI: 10.1002/gcc.1171
Copyright © 2001 Wiley-Liss, Inc.
Additional Information
How to Cite
Wang, Y. L., Bagg, A., Pear, W., Nowell, P. C. and Hess, J. L. (2001), Chronic myelogenous leukemia: Laboratory diagnosis and monitoring. Genes Chromosom. Cancer, 32: 97–111. doi: 10.1002/gcc.1171
Publication History
- Issue published online: 29 AUG 2001
- Article first published online: 25 JUL 2001
- Manuscript Accepted: 8 APR 2001
- Manuscript Received: 23 DEC 2000
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , Acquired Mutation of the Tyrosine Kinase JAK2V617F in Egyptian Patients with Myeloid Disorders, Genetic Testing and Molecular Biomarkers, 2011, 15, 1-2, 17
- 2, , Translating Trial-Based Molecular Monitoring Into Clinical Practice: Importance of International Standards and Practical Considerations for Community Practitioners, Clinical Lymphoma Myeloma and Leukemia, 2011, 11, 5, 385
- 3
- 4, , , , , , , , , , , , , , , Comparison of the Cytogenetic and Molecular Analyses in the Assessment of Imatinib Response in Chronic Myelocytic Leukemia, Genetic Testing and Molecular Biomarkers, 2009, 13, 5, 599
- 5, , , , , , Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9, Cancer Genetics and Cytogenetics, 2009, 194, 1, 30
- 6, , , , , , , , Persistence of derivative chromosome 22 after achieving a major molecular response in chronic myeloid leukemia with a cryptic BCR-ABL1 fusion gene, International Journal of Hematology, 2009, 90, 5, 623
- 7, , , , , , Specific assessment of BCR–ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients, European Journal of Haematology, 2009, 82, 4Direct Link:
- 8
- 9, , , , Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods, Blood, 2007, 111, 4, 1774
- 10, , , , , , Rapid detection of BCR-ABL fusion genes using a novel combined LUX primer, in-cell RT-PCR and flow cytometric method, Annals of Hematology, 2007, 87, 1, 35
- 11
- 12, , Cytogenetic testing for therapeutic indication in cancer, Expert Review of Molecular Diagnostics, 2005, 5, 1, 23
- 13, , , , , , , , , , , Assessment of the response to imatinib in chronic myeloid leukemia patients – comparison between the FISH, multiplex and RT-PCR methods, European Journal of Haematology, 2004, 73, 4Direct Link:
- 14, , Clinical implications of advanced molecular cytogenetics in cancer, Expert Review of Molecular Diagnostics, 2004, 4, 1, 71
- 15
- 16, , , Clinical Applications of BCR-ABL Molecular Testing in Acute Leukemia, The Journal of Molecular Diagnostics, 2003, 5, 2, 63
- 17, , Impact of molecular cytogenetics on localization and identification of cancer-related genes in endocrine tumor development, Current Opinion in Endocrinology and Diabetes, 2003, 10, 3, 176
- 18, Innovations in the Management of Leukemia, Cancer Nursing, 2003, 26, Supplement 6S, 26S???31S
- 19
- 20, , Molecular monitoring of chronic myeloid leukemia, Seminars in Hematology, 2003, 40, 2, 62
- 21, , , Multiplex RT-PCR for the Detection of Common BCR-ABL Fusion Transcripts in Paraffin-Embedded Tissues From Patients With Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia, Diagnostic Molecular Pathology, 2003, 12, 3, 119
- 22
- 23, , , , , , , , , RARA fluorescence in situ hybridization overcomes the drawback of PML/RARA fluorescence in situ hybridization in follow-up of acute promyelocytic leukemia, Cancer Genetics and Cytogenetics, 2002, 139, 2, 104

1098-2264/asset/olbannercenter.jpg?v=1&s=171ee740767c9043cf5fcac8ef2214d9bb83ee9c)
1098-2264/asset/cover.gif?v=1&s=c0e0e06a67e833d9809b12a52037db655adeaac1)